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The cryopreservation and autotransplantation of ovarian tissue is emerging as a powerful approach for pre-
serving fertility. However, for cancer patients, it may not be possible to transplant ovarian tissue due to the risk
of re-seeding disease. We investigated strategies for transplantation of individually isolated follicles to mini-
mize the risk of re-introducing cancer cells present within the vasculature of ovarian stroma. Procedures for
large-scale isolation of early-stage follicles and their encapsulation into fibrin hydrogels were developed. For
in vivo validation studies, mice were ovariectomized and transplanted with encapsulated follicles into the
ovarian bursa. A substantial increase in the number of secondary follicles was observed in the graft at 9 days
after transplantation, and antral follicles by day 21, demonstrating primordial follicle recruitment into the
growing pool. Initially, elevated follicle-stimulating hormone levels declined substantially by day 21, indicating
feedback from the graft; presence of corpora lutea showed the graft’s capability of restoring hormone cyclicity.
Taken together, the transplanted follicles were able to engraft, mature, and restore ovarian function in an
infertile mouse. This biomaterial may, thus, provide a platform for follicle transplantation with a low risk of
cancer contamination and for developing strategies that preserve fertility for women facing a cancer diagnosis.
Introduction
Cancer patients’ concern for their future fertility rankssecond only to concerns about mortality, which has
motivated the pursuit of strategies that preserve fertility.1
Unfortunately, many chemotherapies are fertility threatening;
in particular, alkylating agents and platinum-based drugs are
highly associated with post-treatment infertility, as they cause
DNA damage to the oocytes that comprises the ovarian re-
serve.2–4 Most young women with cancer are interested in
trying to preserve their fertility so they might have children in
the future.5 While there have been promising results with
fertility preservation, some of these techniques can require
more time than is available to the patient or are not feasible
depending on the patient’s age or relationship status, among
other variables.6 The traditional approach for fertility pres-
ervation involves hormonal stimulation, and subsequent egg
or embryo banking; however, this option has constraints on
its applicability, such as the nature of the disease, and
availability of a male partner or willingness to use a sperm
donor. Furthermore, egg retrieval requires hormonal stimu-
lation that is time consuming and may have unwanted effects
on women with hormone-responsive cancers. Moreover, pe-
diatric patients cannot use in vitro fertilization technology for
oocyte or embryo banking.
The cryopreservation and autotransplantation of ovarian
tissue is emerging as a powerful approach for preserving
fertility for patients who are losing ovarian function.7
Ovarian tissue transplantation has resulted in at least 24
published live births,8–20 20 of which were preceded by a
freeze-thaw cycle,21 and at least 1 legal pregnancy termi-
nation after cancer recurrence.22 The number of live births
demonstrates the feasibility of the approach, yet also indi-
cates that advances are needed to make the procedure more
widespread and safe. A primary focus of transplantation is
the primordial follicle, which is the most immature follicle
stage and is the most abundant follicle stage in the ovary
( > 70%) for women before perimenopause.23 In addition to
primordial follicles, the ovary contains follicles at multiple
stages of development (primary, preantral, and antral), along
with stromal tissue. Harnessing the potential of these earli-
est-stage follicles to develop and produce mature eggs may
provide greater opportunities for fertility preservation. In
addition, transplantation of tissue with a large number of
follicles could both restore endocrine function and produce
multiple cycles for conception.
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In this article, we investigated the engraftment and
function of transplanted ovarian follicles as an alternative to
transplantation of ovarian tissue. We focused on the trans-
plantation of primordial follicles, which are the earliest-
stage follicles and are present in the ovary in the greatest
numbers, and aimed at supporting their engraftment and
resumption of endocrine function. Follicles along with a
small number of passenger stromal cells were delivered into
the ovarian bursa in mice, and were encapsulated within
fibrin hydrogels that support the isolated follicles in the ab-
sence of intact stromal tissue. Fibrin has been employed as a
surgical sealant; however, it is also employed as a versatile
scaffold for tissue engineering24 and as a vehicle for cell and
tissue transplantation,24–27 which is due, in part, to its gelation
under physiological conditions (isotonic, 37C, and a pH 7.4).
Human ovarian follicles have been transplanted into immu-
nocompromised mice,11,28 with the follicles able to enter the
growing pool. However, the functionality of the transplanted
follicles was not addressed, in part, due to the long times for
development and differences in hormones and cycles between
mice and humans. Here, the functionality of the transplanted
grafts was assessed through histology, hormone production,
and resumption of the estrous cycle of the recipient. Systems
for the efficient transplantation of ovarian follicles may ulti-
mately provide novel options to preserve fertility for women
facing a cancer diagnosis.
Materials and Methods
Fibrinogen preparation
Fibrinogen (Calbiochem) was reconstituted in water at
62.5mg/mL. The fibrinogen solution was aliquoted in dialysis
tubing (MWC 6–8 kDa; SpectraPor) and placed in excess Tris
buffered saline overnight. Purified fibrinogen solution was
adjusted to 40mg/mL and stored until use at - 20C.
Ovarian tissue digestion
The procedure for large-scale isolation of early-stage
follicles was based on three rounds of alternating chemical
and mechanical digestion. Ovaries were dissected from 6-
day-old F1 hybrid (C57Bl/6J ·CBA/Ca) female pups, which
have large numbers of primordial follicles, and transferred
to Leibovitz L-15 (Gibco) media containing 0.15Wu¨nsch
units/mL Liberase TM (Roche). Liberase, a purified enzyme
blend, has previously been shown to yield highly viable and
morphologically unaltered primordial and primary follicles in
contrast to conventional collagenase blends containing en-
dotoxins and other impurities.29 Ovaries were digested for
1 h, and gently sheared with a P10 pipette tip at 15-min in-
tervals during the digest. Before each shearing, tissue was
washed in 400mL L-15 media before shearing in 400mL L-15
containing 1% fetal bovine serum (FBS). Digestion, washing,
and shearing were done in a 9-cavity Pyrex plate (Electron
Microscopy Sciences) on a 30C heating stage, as physio-
logical temperature (37C) leads to excessive evaporation and
media hypertonicity during the procedures. The digestion was
quenched by adding 50mL FBS to the shearing well.
Ovarian tissue digestion and follicle isolation
Digested tissue was recovered under an inverted dissect-
ing microscope by collecting 200 mL from the base of the
cavity and transferring to a centrifuge tube for sedimentation
to separate follicles from digested tissue. The sedimentation
velocity of a primordial follicle (r = 20 mm), from a sus-
pension of digested, single cells, was estimated to be
7.8 · 10 - 4 m/s from the following equation:
¼ 2r
2(q q0)g
9l
,
where v is the sedimentation velocity, r is the radius of
the follicle or cell, q is the known density of Chinese
Hamster Ovary cells (1.06 g/cm2), and q0 and l are the density
and viscosity of water.30 The sedimentation time is dependent
on the height of 200mL volume in a 0.6mL centrifugation
tube, which was determined to be *1.3 cm. Based on the
earlier approximation, a primordial follicle would fall this
distance in 17min in pure water. In contrast, an arbitrary cell
type with a radius of 5mm would be expected to sink only
0.33 cm in 17min. Empirically, a 30min sedimentation time
was used to account for potential error in approximations
and assumptions. One hundred ninety microliters of super-
natant is discarded after sedimentation. The follicle pellet is
re-suspended in the remaining 10 mL volume.
Encapsulation in fibrin hydrogels
The follicle suspension was mixed at a 1:1 volume with
40mg/mL fibrinogen solution. Ten microliters of this mix-
ture was injected into an isotonic Tris encapsulation buffer
(17.5mM Tris, 105mM NaCl, and 40mM CaCl2) at 37C
containing 50 IU/mL thrombin (Sigma-Aldrich). The gela-
tion period was 5min before the formed hydrogels were
transferred to L-15 media at 37C, where they were main-
tained until transplantation.
Animal husbandry and care
Female C57Bl/6J mice ( Jackson) were paired with male
CBA/Ca (Harlan) mice to obtain C57Bl/6J ·CBA/Ca F1
hybrids that were both used as pups for tissue donation and
weaned as transplant recipients. The animals were main-
tained in a temperature-controlled room, on a 14:10 light:
dark schedule with access to food and water ad libitum.
Animals were treated in agreement with the NIH Guide for
the Care and Use of Laboratory Animals and the IACUC
protocol at Northwestern University.
Ovariectomy and transplantation
Before any surgical procedure, anesthesia was provided
by an intraperitoneal injection of 100mg/kg ketamine and
5mg/kg xylazine. Ovaries were removed from the ovarian
bursa as previously described31 in adult females (12–16
weeks of age) with some modification. Briefy, a midline
incision was made in the abdominal wall. The intraperito-
neal space was exposed with an abdomen retractor. Below
the fat pad, a small incision was made in the bursal mem-
brane, and the host ovary was removed at the hilum. To
prevent collapse of the bursal cavity before re-transplantation,
a 10mL alginate (1.0% w/v) bead was placed into the
membrane. The bursal membrane was then closed with 10-0
sutures. Animals were kept on a heated stage during surgery
and recovery to prevent hypothermia. Females who did not
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have an estrous cycle, as determined by daily vaginal cy-
tology, received a graft in both orthotopic sites at 14–21
days after ovariectomy as described earlier after removal of
the alginate bead.
Vaginal cytology was performed daily starting at 5 days
after ovariectomy for at least 8 days, a time over which
normally cycling mice would be expected to have two cycles.
After transplantation, vaginal cytology was again begun after
5 days, and was monitored for 2 weeks. The appearance of at
least one cycle was counted as resumed cycling.
Serum follicle-stimulating hormone levels
Tail blood was collected weekly in a 53⁄4" glass pasteur
pipette. At the time of sacrifice, blood was collected via heart
puncture. Blood was drained into a gel StatSampler centrifuge
tube (Iris) and immediately sealed to prevent evaporation. The
sample was allowed to clot for 1 h at room temperature.
Serum (20mL) was aspirated from the sample after centrifu-
gation at 5400 rpm for 15min and stored at - 20C. The
sample was diluted 10-fold for determination of follicle-
stimulating hormone (FSH) levels via radioimmunoassay
(Ligand Assay and Analysis Core Facility, University of
Virginia Center for Research in Reproduction).
Histological tissue analysis
Tissue and fibrin hydrogels were fixed in 4% buffered
formaldehyde at 4C overnight and transferred to 70%
EtOH at 4C until they were processed. Samples were em-
bedded in paraffin, serially sectioned at a 5 mm thickness,
and stained with hematoxylin and eosin (H&E). All devel-
opmental stages of follicles were quantified by counting the
nucleolus every-other section to prevent counting a follicle
more than once. Individual tracking of follicles through
sequential slides confirmed that a nucleolus appears in an
average of 1.9 and 2.0 sections in the fixed fibrin hydrogels
(n = 31) and ovarian tissue (n = 37), respectively. A follicle
was classified as primordial only if the surrounding granu-
losa cells were squamous. Follicles with a mix of squamous
and cuboidal granulosa cells, or a single layer of cuboidal
cells, were considered primary follicles. Two or more layers
of cuboidal granulosa cells defined a secondary follicle, and
the presence of a fluid-filled antrum defined an antral fol-
licle. Corpora lutea were evident based on extensive per-
meation of red blood cells into the ovulated follicle.
CM-DiI staining and visualization
After 15min of sedimentation, 100 mL was aspirated from
the digestion product; 0.5 mL of a 2mg/mL stock of Cell-
Tracker CM-DiI (Invitrogen) was added, incubated for
3min at 37C, and then placed on ice for 15min for further
sedimentation.32,33 DiI-labeled follicles were encapsulated
in fibrin hydrogels as described earlier and immediately
transplanted. After sacrifice, the ovary and surrounding tis-
sue was fixed and processed as described earlier. Samples
were de-paraffinized and labeled with VECTASHIELD
Mounting Medium with DAPI (Vector Laboratories). Sam-
ples were counterstained with hematoxylin for follicle pool
quantification and images using a Nikon Eclipse E600 mi-
croscope (Nikon).
Statistical analysis
Follicles in stained histology samples were counted and
classified by developmental stage, and average numbers and
standard error of the mean were reported (Tables 1 and 2).
Statistical analyses (one-way ANOVA) were performed
using the software Prism 4.0 (GraphPad Software). A dif-
ference was considered significant if the p-value was < 0.05.
Results
Maintaining the orthotopic site after ovariectomy
Mice were bilaterally ovariectomized, which was per-
formed 2 weeks before transplantation. The bursa was
opened, the ovary was removed, and this orthotopic site was
Table 1. Follicle Population Delivered in Fibrin Hydrogels
Follicle developmental stage
Primordial Primary Secondary Antral Sum
Number (Avg – SEM) 277 – 96 13.5 – 4.4 4.3 – 2.8 0– 0 295– 102
Distribution (% of total) 94 – 1 4.7 – 0.6 1.2 – 0.6 0– 0 100
Fibrin hydrogels with encapsulated follicles were immediately fixed, rather than transplanted (n = 6), and the population was
characterized by manual counting after histological preparation.
SEM, standard error of the mean.
Table 2. Follicle Development Distribution Within the Graft
Time post-Tx
(days)
Primordial (%)
[follicle no.]
Primary (%)
[follicle no.]
Secondary (%)
[follicle no.]
Antral (%)
[follicle no.]
0 (n = 6) 94– 1a [1661] 5– 1d [81] 1.2 – 0.6f [29] 0h [0]
3 (n = 4) 89– 3a [657] 11– 3d [101] 0f [4] 0h [0]
9 (n = 6) 49– 7b [318] 46– 6e [326] 5– 2f [31] 0h [0]
21 (n = 5) 17– 4c [88] 34– 4e [179] 41– 6g [265] 8h – 1i [48]
Percentages of primordial, primary, secondary, and antral follicles as a function of time after transplantation. Statistical analysis within
each column was performed as a one-way ANOVA. Different letters indicate a significant different within that column ( p < 0.05). No
statistical comparison was made between columns.
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preserved until follicle transplantation by implanting an al-
ginate bead (Fig. 1a). Histology images confirm that no
cellular infiltration into the material occurred, nor was in-
flammation present at the host-material interface (Fig. 1b).
Maintenance of the space within the bursa is crucial to
support blood vessel ingrowth to the graft. If either no
biomaterial or a degradable biomaterial was inserted, the
bursa collapsed and adhesions developed that made surgical
placement of the graft impossible (Fig. 1c, d). The 2-week
period between ovariectomy and transplantation was used to
disrupt the negative feedback loop of the hypothalamus-
pituitary-gonad axis, which stops cycling in the mice and
leads to elevated levels of FSH. FSH levels were below the
detection limit ( < 20 ng/mL) before ovariectomy and
reached an average of 61.2 – 12.9 ng/mL (n = 15) by the day
of transplantation.
Encapsulation of an immature follicle pool
in a fibrin hydrogel
We subsequently developed procedures for large-scale
isolation of early-stage follicles and their encapsulation into
fibrin hydrogels. Follicles were isolated by a combination of
mechanical and enzymatic digestion, and after digestion, the
follicle population was enriched relative to individual
cells by sedimentation without centrifugation (Table 1).
The number of stromal cells associated with the follicles
averaged 40 – 20 stromal cells per follicle. The isolated
follicles were then encapsulated within fibrin hydrogels,
which were examined by H&E staining to verify main-
tenance of follicle morphology (Fig. 2a). Factors con-
sidered in analyzing the morphology were a centrally
located oocyte (the germ cell) enclosed by somatic granulosa
cells and lack of fragmentation of the oocyte (Fig. 2b, c).
Analysis of the fibrin-encapsulated follicles indicated mor-
phologically intact follicles, with a population distribution of
94% primordial follicles, 4.7% primary follicles, and 1.2%
secondary follicles. These results demonstrate the potential for
large-scale isolation and encapsulation of morphologically
intact follicles.
DiI confirms the donor origin of grafted tissue
Follicle survival, morphology, and distribution of classes
were subsequently investigated after transplantation of DiI-
labeled follicles. DiI-labeled follicles (Fig. 3A–C) were
readily observed in histological sections and distinguish-
able from native ovarian tissue at days 3, 9, and 21 post-
transplantation, with numerous early-stage follicles readily
seen within the transplant (Fig. 3D–I). Host ovarian tissue
was negative for DiI fluorescence (Supplementary Fig. S1;
Supplementary Data are available online at www.liebertpub
.com/tea). The population distribution at day 3 was similar to
the distribution reported after fibrin encapsulation (Fig. 4A),
which was expected as the transition from an activated pri-
mordial to a primary follicle takes *1 week. Although the
follicle distribution was similar pre- and post-transplantation,
the graft morphology at day 3 differed significantly from that
observed in the fibrin hydrogel pre-transplantation. Before
transplantation, the follicles were dispersed throughout the
hydrogel. At day 3, however, the ovarian follicles had coa-
lesced into one or more small pieces of tissue, and an intact
FIG. 1. Maintenance of the
ovarian orthotopic site with an al-
ginate bead. (a) An alginate bead
(Alg) was placed in the ovarian
bursa (arrows) so that ovarian tis-
sue could be transplanted at 14
days after ovariectomy. The inci-
sion is denoted by the presence of
sutures (arrow head). (b) Neither
cellular infiltration nor inflamma-
tion is observed at the host material
interface of the alginate (Alg) and
ovarian bursa (arrows). Blood ves-
sels (BV) are observed within the
bursa, which may initially support
the transplant. (c) The absence of
an alginate bead leads to collapse
of the bursa, resulting in dense
connective tissue. Sutures that
identify the bursal tissue are de-
noted by arrow heads. (d) Magni-
fication of the sutures (S) used to
identify connective tissue as the
collapsed bursa. Scale bars are
250 mm (a, c) or 25 mm (b, d), F
denotes fat tissue, Color images
available online at www.liebertpub
.com/tea
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fibrin hydrogel was not observed (Fig. 3D, G) likely due to
the degradation of fibrin. No significant effect of ischemic
injury was apparent at day 3, as the population had not
significantly changed between isolation and day 3.
At day 9, the graft was identified with DiI labeling,
though the morphology of the graft also distinguished it
from the host (Fig. 3B, E). The graft contained primordial
follicles; however, a substantial increase in the number of
secondary follicles was observed (Fig. 4B). The primordial
follicles were recruited into the growing pool. A decrease in
follicle survival was observed at 9 days post-transplantation
(Fig. 4A). The follicle numbers did not decrease further
between 9 and 21 days, suggesting that the first week after
transplantation is the critical time for influencing follicle
survival.
At day 21 of transplantation, grafts could be identified
morphologically and with DiI staining (Fig. 3C, F), though
the fluorescence intensity from DiI had significantly de-
creased relative to day 3. Day 21 was selected as that is the
time reported for a primordial follicle to develop into a fully
mature pre-ovulatory follicle, or a corpus luteum (CL) if an
luteinizing hormone surge occurs.34 The grafts contained
primordial, primary, secondary, and antral follicles. Antral
follicles, the final stage of follicular development before
ovulation, were identified by the presence of a fluid-filled
cavity called the antrum (Fig. 3I). Less than 20% of the total
follicle pool remained in primordial stage of development,
and the remainder of the pool consisted of primary, second-
ary, and antral follicles (Fig. 4B). Between the time of
transplantation and day 21, an 83% reduction of the follicle
pool was observed (Fig. 4A). Interestingly, the grafts attached
exclusively to the bursal tissue, as opposed to the ovarian
hilum, which supplies the majority of the blood to the ovary.
Assessment of graft function
The function of the graft was assessed with serum hor-
mone levels of FSH in transplant recipients. The number of
grafts retrieved from mice in which the biomaterial and
surviving follicles were observed was high at the initial time
points, but declined to*40% of the mice by day 21 (Fig. 5).
This percentage reflects the challenge in identifying fibrin in
the implantation site due to its degradation. The FSH levels
were relatively low (&20 ng/mL) at the time of ovariectomy
and increased to *60 ng/mL before transplantation (Fig.
6A). The FSH levels remained relatively constant during the
first 2 weeks after follicle transplantation. However, by day
21 post-transplantation, the FSH levels had declined sub-
stantially. The levels remained greater than the initial levels
before transplantation. Graft function, as observed with the
reduction in FSH levels, was further confirmed by daily
vaginal cytology, where 8 of 10 mice that were previ-
ously luteal (noncycling) for more than 1 month resumed
cyclicity. In addition, large antral follicles (Fig. 6B) and
post-ovulatory follicles or CL (Fig. 6C) were observed in
histological sections for four out of five mice at 21 days
post-transplantation. The CL was positive for CM-DiI
staining, confirming the transplant origin, and had the typ-
ical hallmarks: centrally located blood clot, alignment of the
stromal cells relative to the blood clot, and the lack of an
oocyte and a basement membrane (Fig. 6C). Thus, the fol-
licle pool survival and activation observed in histological
analysis was in agreement with physiological changes of the
mouse, indicating a functional graft.
Discussion
This article demonstrated the use of fibrin hydrogels for
the transplantation of isolated ovarian follicles, which sur-
vived, were recruited into the growing pool, and were able
to restore endocrine function that was usually performed by
the ovary. The early-stage follicles that were transplanted
developed into antral follicles, and corpora lutea were ob-
served, suggesting an ovulatory event. The presence of an-
tral follicles at day 21 is consistent with the time for
primordial follicle activation, in which primordial follicles
FIG. 2. Encapsulation of an ovarian follicle pool in a fibrin hydrogel. (a) Representative image of a cross-section of
follicles encapsulated within the fibrin hydrogel. The edge of the fibrin hydrogel is indicated with black arrows. (b) A
secondary follicle (open arrow head) and primary follicle (closed arrow head) with a centrally located oocyte (Oo) and
surrounding cuboidal granulosa cells (GC). (c) Primordial follicles with an oocyte and squamous granulosa cells. Scale bars
are 250mm (a) or 25mm (b, c). Color images available online at www.liebertpub.com/tea
FIBRIN-ENCAPSULATED FOLLICLE POOL TRANSPLANTATION 3025
FIG. 4. Follicle development and attrition. (A) Number of follicles as a function of time in the graft. Different letters
above bars indicate significant difference ( p < 0.05). (B) Percentage of follicles in each developmental stage within the
graft. The n was 6, 6, 10, and 12 for day 0, 3, 9, and 21, respectively.
FIG. 3. DiI staining confirms origin of grafted tissue. (A) CM-DiI stained follicles in retrieved tissue at day 3 (A), day 9
(B), and day 21 (C). The corresponding hematoxylin counterstaining is shown in (D–F). DAPI and CM-DiI are blue and red,
respectively. Graft is denoted by g. (G) Hematoxylin and eosin staining of histological sections identified primordial
follicles (denoted by an *) within the graft at day 3 h. At day 9, primary follicles (**) are observed within the graft. (F) After
21 days, some antral follicles are present (***). Scale bars are 100, 25, and 50 mm in (A–F, G), and (H–I), respectively.
Color images available online at www.liebertpub.com/tea
3026 SMITH ET AL.
require*21 days to reach maturity as a pre-ovulatory antral
follicle. Interestingly, the presence of antral follicles also
correlated with a decline in FSH levels. In healthy mice,
antral follicles produce high levels of estrogens in their
granulosa cell compartment, which feedback to reduce FSH
secretion by the pituitary gland in a cycling, fertile mouse.
This time at which FSH levels began to decline is consistent
with a previous report using the same mouse model that
investigated the transplantation of ovarian tissue.27 Other
groups have similarly had success with transplants and here,
we extend this work to show the functionality of the graft
through endocrine hormone assessment. The long-term goal
of this work is to develop a bioengineered transplant ap-
proach for restoring human ovarian function in the location
of the original ovary. The methods described here represent
the first step toward this ultimate goal.
The limited stromal support was anticipated to be a sig-
nificant factor limiting follicle survival and function, and a
biomaterial was employed as a temporary support to
maintain follicular structure until ingrowth of the host
stromal cells. Fibrin enabled follicle encapsulation under
conditions that maintained high cell viability. The isolation
process can disrupt some cell–cell interactions within the
follicle, though oocytes and somatic cells can reform con-
nections, which are likely facilitated by encapsulation
within the biomaterial.35,36 The isolation process resulted in
modest levels of passenger stromal cells; nevertheless, the
gels also provided a physical connectivity between the graft
and host, and, thus, stromal cells infiltrate the graft and
surround the follicles. The stromal cells, both endogenous
and passenger, may contribute to engraftment and function
of the transplanted follicles. Fibrin hydrogels, which are
degradable and support cell ingrowth and integration with
the host rather than isolation, have been widely used as
surgical sealants, tissue engineering scaffolds, drug delivery,
and cell and tissue transplantation.24–27,37 At the time of
encapsulation, follicles are distributed throughout the hy-
drogel; however, they were observed in close proximity at
days 9 and 21 post-transplantation, which may have resulted
from fibrin degradation. The distribution of follicles within
the implant is a critical design consideration that will require
further study. The initially sparse density may have enabled
follicle activation into the growing pool, as primordial fol-
licles are usually at high density in the ovary, which may
serve to modulate their growth.38 However, the subsequent
aggregation between days 9 and 21 may have contributed to
follicle survival and growth,38,39 as paracrine signaling in-
fluences follicle growth. While follicle transplantation has
many challenges that are noted earlier, a potential advantage
of this approach is the delivery of a known number and
density of follicles. In tissue transplantation, the number of
follicles may be unknown or heterogeneous, and isolation of
follicles for transplantation in a biomaterial offers the op-
portunity to standardize the transplant procedures.
FIG. 5. Graft survival. Graft survival was determined by
the presence of transplanted follicles within the harvested
bursa. Note that samples were harvested at each time point
for analysis by histology, and the n for each time point was
6, 6, 10, and 12 for day 0, 3, 9, and 21, respectively.
FIG. 6. Graft function. (A)
Follicle-stimulating hormone
(FSH) levels within the
serum were measured
pre-ovariectomy,
post-ovariectomy but pre-
transplantation, and post-
transplantation. Statistical
analysis was performed using
a one-way ANOVA. (B) Large
antral follicles and (C)
corpora lutea were observed
at 21 days post-transplantation
in four of five mice, in
agreement with the FSH
levels. The corpus (dashed
outline) luteum supports the
occurrence of ovulation. Scale
bars= 100mm. Color images
available online at www
.liebertpub.com/tea
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While transplanted follicles form mature follicles over
time, the number of follicles and percentage of primordial
follicles in the graft declines throughout 21 days. Recent
reports have focused on relative short-term studies, with a
reduction of 50% of follicles through 7 days.40,41 An 83%
reduction of the follicle pool was observed through 21 days,
with most of the decrease occurring during the first 9 days
post-transplantation. The decline in follicle numbers was
expected to result from limited follicle survival and follicle
atresia after activation. Interestingly, this decline in follicle
numbers is greater than what is observed with ovarian tissue
transplantation (unpublished observations). A major factor
in cell survival is revascularization, which has been reported
to occur at about 2–5 days post-transplantation.42,43 Is-
chemic injury has been estimated to significantly decrease
the size of the follicle pool.44 Interestingly, the ovary re-
ceives the majority of its blood supply from the ovarian
hilum; however, the surviving follicles were observed ad-
jacent to the bursal tissue. Follicle atresia after follicle ac-
tivation likely also contributes to the decline in follicle
number, as not all follicles that enter the growing follicle
population develop to antral follicles.45 The number of
primordial follicles that enter the growing pool is not likely
to be influenced by the high levels of FSH for the 14 days
after transplantation as receptors for this ligand are not
present.27 Local peptide hormones such as Kit Ligand or
anti-Mullerian hormone have also been implicated in follicle
activation after transplantation46 and could be supplemented
through peptide delivery from the biomaterial. Moreover,
systems biology analysis of follicles across various stages of
development are identifying key factors. Using time series
microarrays, we recently identified cartilage oligomeric
matrix protein (COMP) as a key follicle survival factor,47
and incorporation of these factors into the biomaterial pro-
vides an avenue to further support and promote follicle
development. Finally, these studies investigated transplan-
tation of follicles without significant stroma. Stromal cells
secrete a range of factors that influence follicle activation
and also follicle survival,48–52 and the hydrogel could be
loaded with these cells as a means to augment the transplant
environment.53
Transplantation of individually isolated follicles was in-
vestigated as a means to reduce the risk of re-seeding cancer
cells that may be present within the vasculature or stroma of
the ovary. Ovarian follicle transplantation is viewed as an
intermediate approach within the spectrum of transplant
procedures that are aimed at restoring fertility. At one end of
the spectrum, ovarian tissue is cut into modest size pieces
(i.e., no enzymatic digestion of the tissue) for subsequent
transplant.27 At the other end of the spectrum, the ovary is
completely dissociated into individual cells, and the oocytes
are re-aggregated with somatic cells for transplantation.36
Our approach involves a partial digestion of the tissue,
which also results in modest numbers of passenger stromal
cells with the follicles. Ovarian tissue transplantation has
been successful at fertility preservation. However, trans-
planted ovarian tissue may also contain cancer cells that
pose a significant risk for translation to cancer patients.6,54–62
Cancer cells have the potential to metastasize to the ovary,63–66
or circulating tumor cells may be present within the vas-
culature of the ovary, both of which pose the risk of re-
implanting malignant cells.67 Non-Hodgkins lymphomas,
colon, melanoma, pancreas, gastric, and breast cancer, often
called Krukenberg tumor, can metastasize to the ovary. Our
transplanted follicles contained a modest number of stromal
cells (40– 20 stromal cells per follicle). While this number
of stromal cells may reduce the risk of re-seeding disease
relative to ovarian tissue transplantation or the transplanta-
tion of dissociated cells that were re-aggregated,28,36 further
modifications to the isolation procedure are likely necessary
to further minimize the risk.
Conclusions
Fibrin gels for the transplantation of early-stage ovarian
follicles supported their engraftment and, ultimately, de-
velopment to antral follicles. The fibrin hydrogels provide a
platform for follicle transplantation that provides a support
for the follicle; however, it enables cellular infiltration of
cells from the host that leads to integration of the graft.
Furthermore, the graft was able to reduce systemic FSH
levels and restore cyclicity in a previously noncycling, in-
fertile mouse, which has not been reported in recent reports
with follicle transplantation.40,41 The significant decrease in
follicle numbers and robust activation of primordial follicles
into the growing pool may be addressed through the design
of the local environment, as ovarian tissue transplants do not
demonstrate the same decline in follicle numbers. Thus,
designer environments for follicle transplantation provide
the opportunity for female cancer patients to preserve their
fertility while minimizing their risk of re-seeding disease.
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